# Study of Metabolic and Haemodynamic Effects of Metformin and Glimepiride in Patients With Type 2 Diabetes Mellitus

> **NCT01509001** · PHASE4 · COMPLETED · sponsor: **University of Sao Paulo** · enrollment: 20 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Metformin
- **DRUG:** Glimepiride

## Key facts

- **NCT ID:** NCT01509001
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2012-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01509001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01509001, "Study of Metabolic and Haemodynamic Effects of Metformin and Glimepiride in Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01509001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*